Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant
The company plans to use the funding to advance LYR-210 into a Phase II clinical trial and also explore its development platform in other ENT diseases.
Polaris, ARCH Venture Partners put $15M behind launch of deCODE genetics spinoff NextCODE
Sequencing the genome is one thing, but applying the data produced from that process to clinical care is a whole other thing. A new startup called NextCODE Health has launched with $15 million and a license to use the genomics platform of deCODE genetics to develop sequence-based clinical diagnostics. deCODE, a once-bankrupt Icelandic company now […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
These are the most active VCs in healthcare since 2012
As investments in life science companies have dipped over the past few years, some investors have scaled back investments or walked away from the sector all together. But based on a tally by investment research firm PitchBook in its 2013 Venture Capital Healthcare Report, several firms have made 10 or more investments in pharmaceutical, medical […]
Investors add $30 million to infectious disease vaccine developer Genocea Biosciences
A vaccine developer focused on fighting infectious diseases like HSV-2, Pneumococcus and malaria has just gotten a $30 million vote of confidence from investors. Genocea Biosciences says its ATLAS platform mimics the human T cell immune response in the laboratory, allowing it to identify and test T cell antigens in less time and with more […]
Medicine in a microchip: Implant holds up to 400 doses, could replace needles
Earlier this summer, we saw the first “smart pill” from Proteus Digital Health receive U.S. Food and Drug Administration clearance, a huge step in connecting drug delivery with mobile technologies. So what comes next? It would be years before we see it on the market, but the next generation of smart medicine just may lie […]
‘Painless’ blood draw device using microneedles could be available in 2013
How much more likely would a diabetic be to check his blood sugar regularly, or a nervous patient to fulfill her doctor’s request for blood work, if there were no “ouch” factor involved? Howard Weisman, the CEO of Seventh Sense Biosystems, said the painless blood draw system his company is developing could show us the […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Boston Sci exec takes over Twin Cities-based BridgePoint Medical
Denis Harrington, who until recently was head of sales for Boston Scientific Corp.'s cardiovascular and CRM business, has left the company to become president and CEO of a Twin Cities startup called BridgePoint Medical Inc.
BridgePoint Medical raises $9M for device to unblock blood vessels
BridgePoint Medical Inc. has raised $9.1 million from the sale of equity. The company based in Plymouth, Minnesota, is developing balloon catheter system to treat chronic coronary and peripheral total occlusions, a condition in which clots frequently clog blood vessels.
Cardiac Concepts grabs $27M for sleep apnea pacing device
Cardiac Concepts Inc. has raised $27.2 million from the sale of equity. The company, based in Minnetonka, Minnesota, is developing a pacemaker-like device that uses electricity to treat sleeping disorders.
Trevena grabs $35M to fund trials of heart-failure drug
Trevena Inc. has landed a sizable $35 million Series B round that it hopes will push its lead heart-failure drug through Phase 2 clinical trials. The funding was led by venture heavyweights and existing investors Polaris Venture Partners and New Enterprise Associates. Other previous investors — Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company […]
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Polaris Venture Partners raises $233M of $400M fund
Life sciences and IT investment firm Polaris Venture Partners has raised $233 million of an anticipated $400 million fund, according to a filing with the Securities and Exchange Commission. The $400 million goal appears to represent scaled-down expectations for the venture luminary, which had previously targeted $500 million for its sixth fund, VentureWire reported. Polaris’ […]
Apnex Medical names former BSX and J&J executive as its new CEO
Apnex Medical Inc., a St. Paul-based startup developing technology to treat obstructive sleep apnea (OSA), has named Charles McKhann as its new CEO. McKhann, who previously served as a global vice president of marketing for Boston Scientific Corp.’s (NYSE: BSX) cardiac rhythm management division, replaces founder and executive director Robert Atkinson. While at Johnson & […]
New venture capital chairman could be helpful to health care
There's a belief that Polaris Ventures co-founder Terry McGuire will help health care as the new chairman of the National Venture Capital Association.